GlassScriptPhysician profile
David T Cozart
NPI 1275538498
$1,022.99
in general payments reported to CMS, 2019-2025
18 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.33 · 2020: $184 · 2021: $139 · 2022: $51.10 · 2023: $174 · 2024: $63.17 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $269.42 | 2019-2025 | |
| Kerecis Limited | $137.60 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Phathom Pharmaceuticals, INC. | $126.46 | 2024-2025 | Voquezna |
| Elucent Medical | $66.34 | 2021 | |
| Molli Surgical (US) INC | $56.31 | 2023 | |
| Davol INC. | $52.56 | 2020 | |
| Merit Medical Systems INC | $48.59 | 2021-2025 | Savi Scout, Savi Brachy |
| Medtronic, INC. | $45.28 | 2021-2024 | Pteye Parathyroid Detection System |
| Myriad Genetic Laboratories, INC. | $35.42 | 2021-2024 | Myrisk |
| Conmed Corporation | $35.04 | 2020 | |
| Solventum Corporation | $27.71 | 2025 | Prevena, V.A.C.Ulta |
| Ethicon US, LLC | $25.99 | 2025 | Echelon; Endopath, Proximate |
| Hologic Sales and Service, LLC | $21.81 | 2023 | Sertera Biopsy Device |
| Kci USA, INC. | $19.62 | 2021 | |
| Olympus America INC. | $15.11 | 2025 | Visera Elite Video System Center, Evis Exera III Colonovideoscope |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $14.50 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.83 | 2023 | Livalo, Seglentis |
| Braintree Laboratories, INC. | $12.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cozart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.